RENAGEL is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Sevelamer Hydrochloride.
Product ID | 68151-4295_659e4de8-1232-4c9e-ab20-7e0d3af01700 |
NDC | 68151-4295 |
Product Type | Human Prescription Drug |
Proprietary Name | RENAGEL |
Generic Name | Renagel |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2008-06-06 |
Marketing Category | NDA / NDA |
Application Number | NDA021179 |
Labeler Name | Carilion Materials Management |
Substance Name | SEVELAMER HYDROCHLORIDE |
Active Ingredient Strength | 400 mg/1 |
Pharm Classes | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2017-12-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021179 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-12-28 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
SEVELAMER HYDROCHLORIDE | 400 mg/1 |
SPL SET ID: | 9281598e-60de-4f4f-8e01-0a7dfef92dd3 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
17856-0021 | Renagel | Renagel |
53808-0777 | Renagel | Renagel |
58468-0020 | Renagel | Renagel |
58468-0021 | Renagel | sevelamer hydrochloride |
67544-656 | Renagel | Renagel |
68151-4295 | RENAGEL | Renagel |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RENAGEL 74590044 1978935 Live/Registered |
GENZYME CORPORATION 1994-10-24 |